Home/Filings/4/0001209191-23-048195
4//SEC Filing

Wolterman Dan 4

Accession 0001209191-23-048195

CIK 0001142596other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 5:06 PM ET

Size

25.4 KB

Accession

0001209191-23-048195

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-014,2300 total
    Common Stock (4,230 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,6440 total
    Common Stock (2,644 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,5770 total
    Common Stock (2,577 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-013,7880 total
    Common Stock (3,788 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,1300 total
    Common Stock (2,130 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,7020 total
    Common Stock (2,702 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,8220 total
    Common Stock (2,822 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-013,2300 total
    Common Stock (3,230 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-013,0950 total
    Common Stock (3,095 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-014,8160 total
    Common Stock (4,816 underlying)
Footnotes (2)
  • [F1]Represented a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award.

Issuer

NUVASIVE INC

CIK 0001142596

Entity typeother

Related Parties

1
  • filerCIK 0001586330

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 5:06 PM ET
Size
25.4 KB